Tag Articles

What Monica Lewinsky and Indian generic drugs have in common – Bill Clinton loves them both

April 12, 2013
While Big Pharma and other US companies are fuming against Indian generic drugs and the pharma industry, former president Bill Clinton lauded Indian drug companies like Ranbaxy and Cipla for their huge contribution in the battle …

Novartis protests against ‘evergreening’ allegation, says Imatinib was an invention

April 3, 2013
India's apex court is in the witness box facing not-so-subtle protests from the $56.67-billion Swiss drugs giant Novartis that is on the losing side of a far-reaching ruling this week on the crucial area of innovation, research …

Now government hospitals in Maharashtra to use generic drugs

April 3, 2013
It seems the state government has finally woken up to the possibility of subsidised healthcare. According to the recent Supreme Court ruling, the state government has decided to use Generic drugs for all medicine supplies to …

SC ruling on Novartis applauded by health experts

April 1, 2013
The landmark ruling of the Supreme Court, rejecting Swiss drug maker Novartis AG's attempt to patent its cancer drug, has been welcomed by health experts saying the dictum would ensure that patients get access to cheaper …

Novartis AG loses patent battle, cancer drugs to be cheaper

April 1, 2013
In a landmark judgement, the Indian Supreme court dismissed the patent plea for an anti-cancer drug called Glivec by Novartis AG. Anti-leukaemia drug Glivec is one of the blockbuster drugs for the Swiss company, mopping up global …

‘South Africa must follow India, China lead on affordable life-saving drugs’

March 27, 2013
The South African government must follow the lead of its BRICS peers like India and China to ensure that life-saving medicines are affordable, said Doctors without Borders (or Medecins Sans Frontieres), an international …

Why has the National Health Bill been shelved?

March 25, 2013
Our government, in fact all Indian governments irrespective ideology age seem to suffer from a condition that can only be described as red-tape amnesia. Or maybe it’s a clever ruse to forget about things that could increase …

Global Big Pharma targeting Indian pharmaceutical industry?

March 20, 2013
As Indian pharmaceutical companies face charges of selling counterfeit drugs in Africa, India has dubbed the allegations as ‘calculated attempts’ by Western cartels to destroy its march to provide affordable medicines. …

Africa seeks Indian investment in healthcare

March 19, 2013
Several African countries are seeking Indian investment in tertiary healthcare and supply of affordable medicines to its population. According to Hussain Ali Mwinyi, Tanzania's health minister, the best way to increase abilities …

India vs Big Pharma: Compulsory licence for leukaemia drug sought

March 19, 2013
That the compulsory licence verdict in favour of NATCO Pharma would change the landscape of the pharma industries the world over was never in doubt. The verdict was hailed as ‘revolutionary’, ‘path-breaking’ and hailed as …

Mamata Banerjee battles for generic drugs

March 16, 2013
‘If you don't cooperate with patients, we won't tolerate that. We will cancel your licence,’ the stern warning from West Bengal Chief Minister Mamata Banerjee left the middle-aged chemist trembling on the other side of the …

Fair price shops to sell generic medicines in West Bengal

March 4, 2013
The West Bengal government is pushing generic drugs in a big way to replace expensive branded medicines and bring down the prices of essential drugs.Generic drugs cost less than branded ones, and the price difference is mainly …

‘Compulsory licence verdict doesn’t violate multilateral trade agreement’

January 31, 2013
On Wednesday, India told the US that the compulsory licence given to replicate Bayer’s patented anti-cancer drug Nexavar didn’t violate any multilateral trade agreement. It also said that such a move shouldn’t be seen as …

Govt set to hand out three more compulsory licenses for cancer drugs

January 15, 2013
Recent media reports suggest that the government has appointed a panel to look into issues relating to compulsory licensing of three cancer drugs - Trastuzumab, Ixabepilone and Dasatinib. The health ministry has sent its proposal …